2014 -- S 2505 | |
======== | |
LC003897 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2014 | |
____________ | |
A N A C T | |
RELATING TO INSURANCE | |
| |
Introduced By: Senators Pearson, and Picard | |
Date Introduced: February 27, 2014 | |
Referred To: Senate Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Section 27-18-70 of the General Laws in Chapter 27-18 entitled "Accident |
2 | and Sickness Insurance Policies" is hereby amended to read as follows: |
3 | 27-18-70. Enteral nutrition products. -- (a) Every individual or group health insurance |
4 | contract, or every individual or group hospital or medical expense insurance policy, plan, or |
5 | group policy delivered, issued for delivery, or renewed in this state on or after January 1, 2009, |
6 | shall provide coverage for nonprescription enteral formulas for home use for which a physician |
7 | has issued a written order and which are medically necessary for the treatment of malabsorption |
8 | caused by Crohn's disease, ulcerative colitis, gastroesophageal reflux, chronic intestinal pseudo- |
9 | obstruction, and inherited diseases of amino acids and organic acids. Coverage for inherited |
10 | diseases of amino acids and organic acids shall include food products modified to be low protein |
11 | and shall extend to all recipients regardless of age. Provided, however, that coverage shall not |
12 | exceed an amount of two thousand five hundred dollars ($2,500) per covered member per year. |
13 | (b) Benefit plans offered by an insurer may not impose a copayment and/or deductibles |
14 | for the benefits mandated by this section, however, in no instance shall the copayment or |
15 | deductible amount be greater than the copayment or deductible amount imposed for prescription |
16 | enteral formulas or nutritional aids. Benefits for services under this chapter shall be reimbursed in |
17 | accordance with the respective principles and mechanisms of reimbursement for each insurer, |
18 | hospital, or medical service corporation, or health maintenance organization. Reimbursement |
19 | shall be provided according to the respective principles and policies of the accident and sickness |
| |
1 | insurer. Nothing contained in this section precludes the accident and sickness insurer from |
2 | conducting managed care, medical necessity, or utilization review. |
3 | (c) This section shall not apply to insurance coverage providing benefits for: (1) hospital |
4 | confinement indemnity; (2) disability income; (3) accident only; (4) long-term care; (5) Medicare |
5 | supplement; (6) limited benefit health; (7) specified disease indemnity; (8) sickness or bodily |
6 | injury or death by accident or both; and (9) other limited benefit policies. |
7 | SECTION 2. Section 27-19-61 of the General Laws in Chapter 27-19 entitled "Nonprofit |
8 | Hospital Service Corporations" is hereby amended to read as follows: |
9 | 27-19-61. Enteral nutrition products. -- (a) Every individual or group health insurance |
10 | contract, or every individual or group hospital or medical expense insurance policy, plan, or |
11 | group policy delivered, issued for delivery, or renewed in this state on or after January 1, 2009, |
12 | shall provide coverage for nonprescription enteral formulas for home use for which a physician |
13 | has issued a written order and which are medically necessary for the treatment of malabsorption |
14 | caused by Crohn's disease, ulcerative colitis, gastroespphageal reflux, chronic intestinal pseudo- |
15 | obstruction, and inherited diseases of amino acids and organic acids. Coverage for inherited |
16 | diseases of amino acids and organic acids shall include food products modified to be low protein |
17 | and shall extend to all recipients regardless of age. Provided, however, that coverage shall not |
18 | exceed an amount of two thousand five hundred dollars ($2,500) per covered member per year. |
19 | (b) Benefit plans offered by a hospital service corporation may not impose a copayment |
20 | and/or deductible for the benefits mandated by this section, however, in no instance shall the |
21 | copayment or deductible amount be greater than the copayment or deductible amount imposed for |
22 | prescription enteral formulas or nutritional aids. Benefits for services under this chapter shall be |
23 | reimbursed in accordance with the respective principles and mechanisms of reimbursement for |
24 | each insurer, hospital, or medical service corporation, or health maintenance organization. |
25 | Reimbursement shall be provided according to the respective principles and policies of the |
26 | accident and sickness insurer. Nothing contained in this section precludes the accident and |
27 | sickness insurer from conducting managed care, medical necessity, or utilization review. |
28 | (c) This section shall not apply to insurance coverage providing benefits for: (1) hospital |
29 | confinement indemnity; (2) disability income; (3) accident only; (4) long-term care; (5) Medicare |
30 | supplement; (6) limited benefit health; (7) specified disease indemnity; (8) sickness or bodily |
31 | injury or death by accident or both; and (9) other limited benefit policies. |
32 | SECTION 3. Section 27-20-56 of the General Laws in Chapter 27-20 entitled "Nonprofit |
33 | Medical Service Corporations" is hereby amended to read as follows: |
34 | 27-20-56. Enteral nutrition products. -- (a) Every individual or group health insurance |
| LC003897 - Page 2 of 7 |
1 | contract, or every individual or group hospital or medical expense insurance policy, plan, or |
2 | group policy delivered, issued for delivery, or renewed in this state on or after January 1, 2009, |
3 | shall provide coverage for nonprescription enteral formulas for home use for which a physician |
4 | has issued a written order and which are medically necessary for the treatment of malabsorption |
5 | caused by Crohn's disease, ulcerative colitis, gastroespphageal reflux, chronic intestinal pseudo- |
6 | obstruction, and inherited diseases of amino acids and organic acids. Coverage for inherited |
7 | diseases of amino acids and organic acids shall include food products modified to be low protein |
8 | and shall extend to all recipients regardless of age. Provided, however, that coverage shall not |
9 | exceed an amount of two thousand five hundred dollars ($2,500) per covered member per year. |
10 | (b) Benefit plans offered by a medical service corporation may not impose a copayment |
11 | and/or deductible for the benefits mandated by this section, however, in no instance shall the |
12 | copayment or deductible amount be greater than the copayment of deductible amount imposed for |
13 | prescription enteral formulas or nutritional aids. Benefits for services under this chapter shall be |
14 | reimbursed in accordance with the respective principles and mechanisms of reimbursement for |
15 | each insurer, hospital, or medical service corporation, or health maintenance organization. |
16 | Reimbursement shall be provided according to the respective principles and policies of the |
17 | accident and sickness insurer. Nothing contained in this section precludes the accident and |
18 | sickness insurer from conducting managed care, medical necessity, or utilization review. |
19 | (c) This section shall not apply to insurance coverage providing benefits for: (1) hospital |
20 | confinement indemnity; (2) disability income; (3) accident only; (4) long-term care; (5) Medicare |
21 | supplement; (6) limited benefit health; (7) specified disease indemnity; (8) sickness or bodily |
22 | injury or death by accident or both; and (9) other limited benefit policies. |
23 | SECTION 4. Section 27-41-74 of the General Laws in Chapter 27-41 entitled "Health |
24 | Maintenance Organizations" is hereby amended to read as follows: |
25 | 27-41-74. Enteral nutrition products. -- (a) Every individual or group health insurance |
26 | contract, or every individual or group hospital or medical expense insurance policy, plan, or |
27 | group policy delivered, issued for delivery, or renewed in this state on or after January 1, 2009, |
28 | shall provide coverage for nonprescription enteral formulas for home use for which a physician |
29 | has issued a written order and which are medically necessary for the treatment of malabsorption |
30 | caused by Crohn's disease, ulcerative colitis, gastroespphageal reflux, chronic intestinal pseudo- |
31 | obstruction, and inherited diseases of amino acids and organic acids. Coverage for inherited |
32 | diseases of amino acids and organic acids shall include food products modified to be low protein |
33 | and shall extend to all recipients regardless of age. Provided, however, that coverage shall not |
34 | exceed an amount of two thousand five hundred dollars ($2,500) per covered member per year. |
| LC003897 - Page 3 of 7 |
1 | (b) Benefit plans offered by a health maintenance organization may not impose a |
2 | copayment and/or deductible for the benefits mandated by this section, however, in no instance |
3 | shall the copayment or deductible amount be greater than the copayment of deductible amount |
4 | imposed for prescription enteral formulas or nutritional aids. Benefits for services under this |
5 | chapter shall be reimbursed in accordance with the respective principles and mechanisms of |
6 | reimbursement for each insurer, hospital, or medical service corporation, or health maintenance |
7 | organization. Reimbursement shall be provided according to the respective principles and policies |
8 | of the accident and sickness insurer. Nothing contained in this section precludes the accident and |
9 | sickness insurer from conducting managed care, medical necessity, or utilization review. |
10 | (c) This section shall not apply to insurance coverage providing benefits for: (1) hospital |
11 | confinement indemnity; (2) disability income; (3) accident only; (4) long-term care; (5) Medicare |
12 | supplement; (6) limited benefit health; (7) specified disease indemnity; (8) sickness or bodily |
13 | injury or death by accident or both; and (9) other limited benefit policies. |
14 | SECTION 5. Section 40-6-3.12 of the General Laws in Chapter 40-6 entitled "Public |
15 | Assistance Act" is hereby amended to read as follows: |
16 | 40-6-3.12. Enteral nutrition products. -- (a) As used in this section: |
17 | (1) "Enteral nutrition" means a supplemental feeding that is provided via the |
18 | gastrointestinal tract by mouth (orally), or through a tube, catheter, or stoma that delivers |
19 | nutrients distal to the oral cavity. |
20 | (2) "Nutritional risk" means actual or potential for developing malnutrition, as evidenced |
21 | by clinical indicators, the presence of chronic disease, or increased metabolic requirements due to |
22 | impaired ability to ingest or absorb food adequately. |
23 | (b) The department shall provide for vendor payment of enteral nutrition products in |
24 | accordance with rules and regulations of the department, when determined to be medically |
25 | necessary on an individual, case-by-case basis and ordered by a physician in accordance with |
26 | Rhode Island department of health form(s) on enteral nutrition products. Provided, however, that |
27 | coverage shall not exceed an amount of two thousand five hundred dollars ($2,500) per individual |
28 | per year. |
29 | (c) The determination of medical necessity for enteral nutrition products shall be based |
30 | upon a combination of clinical data and the presence of indicators that would affect the relative |
31 | risks and benefits of the products including, but not limited to: |
32 | (1) Enteral nutrition, whether orally or by tube feeding, is used as a therapeutic regimen |
33 | to prevent serious disability or death in a person with a medically diagnosed condition that |
34 | precludes the full use of regular food. |
| LC003897 - Page 4 of 7 |
1 | (2) The person presents clinical signs and symptoms of impaired digestion |
2 | malabsorption, or nutritional risk, as indicated by the following anthropometric measures: |
3 | (i) Weight loss that presents actual or potential for developing, malnutrition as follows: |
4 | (A) In adults, showing involuntary or acute weight loss of greater than or equal to ten |
5 | percent (10%) of usual body weight during a three (3) to six (6) month period, or body mass |
6 | index (bmi) below 18.5 kg/m2; |
7 | (B) In neonates, infants and children, showing: |
8 | (I) Very low birth weight (lbw) even in the absence of gastrointestinal, pulmonary or |
9 | cardiac disorders; |
10 | (II) A lack of weight gain, or weight gain less than two (2) standard deviations below the |
11 | age appropriate mean in a one month period for children under six (6) months, or two (2) month |
12 | period for children aged six (6) to twelve (12) months; |
13 | (III) No weight gain or abnormally slow rate of gain for three (3) months for children |
14 | older than one year, or documented weight loss that does not reverse promptly with instruction in |
15 | appropriate diet for age; or |
16 | (IV) Weight for height less than the tenth (10th) percentile; and |
17 | (ii) Abnormal laboratory test pertinent to the diagnosis. |
18 | (3) The risk factors for actual or potential malnutrition have been identified and |
19 | documented. Such risk factors include, but are not limited to, the following: |
20 | (i) Anatomic structures of the gastrointestinal tract that impair digestion and absorption; |
21 | (ii) Neurological disorders that impair swallowing or chewing; |
22 | (iii) Diagnosis of inborn errors of metabolism that require medically necessary formula |
23 | used for specific metabolic conditions and food products modified low in protein (for example, |
24 | phenylketonuria (pku) tyrosinemia, homocystinuria, maple syrup urine disease, propionic aciduria |
25 | and methylmalonic aciduria); |
26 | (iv) Prolonged nutrient losses due to malabsorption syndromes or short-bowel |
27 | syndromes, diabetes, celiac disease, chronic pancreatitis, renal dialysis, draining abscess or |
28 | wounds, etc.; |
29 | (v) Treatment with anti-nutrient or catabolic properties (for example, anti-tumor |
30 | treatments, corticosteroids, immunosuppressant, etc.); |
31 | (vi) Increased metabolic and/or caloric needs due to excessive burns, infection, trauma, |
32 | prolonged fever, hyperthyroidism, or illnesses that impair caloric intake and/or retention; or |
33 | (vii) A failure-to-thrive diagnosis that increases caloric needs while impairing caloric |
34 | intake and/or retention. |
| LC003897 - Page 5 of 7 |
1 | (4) A comprehensive medical history and a physical examination have been conducted to |
2 | detect factors contributing to nutritional risk. |
3 | (5) Enteral nutrition is indicated as the primary source of nutritional support essential for |
4 | the management of risk factors that impair digestion or malabsorption, and for the management of |
5 | surgical preparation or postoperative care. |
6 | (6) A written plan of care has been developed for regular monitoring of signs and |
7 | symptoms to detect improvement in the person's condition. Nutritional status should be monitored |
8 | regularly; |
9 | (i) For improvements in anthropometric measures; |
10 | (ii) For improvements in laboratory test indicators; and |
11 | (iii) In children, to assess growth and weight for height. |
12 | (d) Enteral nutrition products shall not be considered medically necessary under certain |
13 | circumstances including, but not limited to, the following: |
14 | (1) A medical history and physical examination have been performed and other possible |
15 | alternatives have been identified to minimize nutritional risk. |
16 | (2) The person is underweight, but has the ability to meet nutritional needs through the |
17 | use of regular food consumption. |
18 | (3) Enteral products are used as supplements to a normal or regular diet in a person |
19 | showing no clinical indicators of nutritional risk. |
20 | (4) The person has food allergies, lactose intolerance or dental problems, but has the |
21 | ability to meet his or her nutritional requirements through an alternative food source. |
22 | (5) Enteral products are to be used for dieting or a weight-loss program. |
23 | (6) No medical history or physical examination has been taken and there is no |
24 | documentation that supports the need for enteral nutrition products. |
25 | SECTION 6. This act shall take effect upon passage. |
======== | |
LC003897 | |
======== | |
| LC003897 - Page 6 of 7 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO INSURANCE | |
*** | |
1 | This act would require insurance coverage of formula and other prescribed food for all |
2 | patients regardless of age, and would also abolish the mandated cap on coverage and any co- |
3 | payments or deductibles in connection with such benefits. |
4 | This act would take effect upon passage. |
======== | |
LC003897 | |
======== | |
| LC003897 - Page 7 of 7 |